ORCHARD PARK, New York, Jan. 17 -- Oncotarget, a peer-reviewed journal that says it encompasses all molecules, pathways, cellular functions, cell types and even tissues that can be viewed as targets relevant to cancer as well as other diseases, published research articles on the following topics in its 2024 annual edition (Vol. 15):

Research Papers:

* ATR inhibition using gartisertib enhances cell death and synergises with temozolomide and radiation in patient-derived . . .

Click here for more information about our products